Drug intelligence / Profile preview

18F-MGX-38

Development stage
Preclinical
Lead developer
Stanford University
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals, Small Molecules
Administration
Intravenous
01

Overview

18F-MGX-38 is a novel, brain-penetrant fluorine-18 labeled positron emission tomography (PET) radiotracer designed for imaging neuroinflammation and innate immune activation. It specifically targets G-protein coupled receptor 84 (GPR84), an immune-metabolic receptor that is highly upregulated on pro-inflammatory myeloid cells (such as activated microglia and macrophages) during central nervous system (CNS) injury or neurodegenerative disease. Developed by researchers at Stanford University, the University of Milan, and the University of Michigan, 18F-MGX-38 features a dimethyl dihydropyrido-isoquinolinone scaffold and exhibits high blood-brain barrier permeability, rapid brain uptake, and favorable in vivo pharmacokinetics. It is currently undergoing preclinical IND-enabling studies to evaluate its utility in imaging innate immune activation in models of CNS diseases.

Other names
18F-MGX38[18F]MGX-38
02

Targets

GPR84

Beyond the preview

Go deeper on 18F-MGX-38.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 18F-MGX-38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call